| 000 | 01520 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511233602.0 | ||
| 264 | 0 | _c19900420 | |
| 008 | 199004s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlimena, G | |
| 245 | 0 | 0 |
_aCytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemia. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cFeb 1990 |
||
| 300 |
_a119-27 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChimera _xgenetics |
| 650 | 0 | 4 |
_aChromosome Aberrations _xgenetics |
| 650 | 0 | 4 | _aChromosome Disorders |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aDe Cuia, M R | |
| 700 | 1 | _aMecucci, C | |
| 700 | 1 | _aArcese, W | |
| 700 | 1 | _aMauro, F | |
| 700 | 1 | _aScrenci, M | |
| 700 | 1 | _aMancini, M | |
| 700 | 1 | _aCedrone, M | |
| 700 | 1 | _aNanni, M | |
| 700 | 1 | _aMontefusco, E | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 5 _gno. 2 _gp. 119-27 |
|
| 999 |
_c2316953 _d2316953 |
||